Cargando…
Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron degenerative disease, and it is hard to diagnose in the early stage, and treatment means are limited, and the treatment effect is unsatisfactory. Therefore, exploring a new effective treatment strategy is urgently needed for...
Autores principales: | Wang, Ke, Li, Yu, Ren, Chao, Wang, Yongjing, He, Wenshan, Jiang, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632491/ https://www.ncbi.nlm.nih.gov/pubmed/34858980 http://dx.doi.org/10.3389/fcell.2021.754630 |
Ejemplares similares
-
Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
por: Chen, Qiao Yi, et al.
Publicado: (2021) -
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
por: Sykova, Eva, et al.
Publicado: (2021) -
Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
por: Sykova, Eva, et al.
Publicado: (2021) -
The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Houghton, O. H., et al.
Publicado: (2022) -
Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis
por: Li, Cheng, et al.
Publicado: (2022)